MGC Pharmaceuticals Limited announced that Mr. Daniel Kendall has ceased in his role as Chief Financial Officer for the Company, with Mr. Roby Zomer, the Company's Managing Director and CEO assuming the interim CFO role and responsibilities until a new CFO is appointed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 AUD | -1.16% | -4.49% | -10.53% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.54% | 6.12B | |
-16.47% | 4.44B | |
-10.16% | 3.14B | |
-0.71% | 3.03B | |
-1.06% | 2.57B | |
+40.09% | 1.87B | |
-0.76% | 1.63B | |
-11.19% | 1.62B | |
-12.74% | 1.53B |
- Stock Market
- Equities
- RGT Stock
- MXC Stock
- News Argent BioPharma Limited
- MGC Pharmaceuticals Limited Announces Executive Changes